306 related articles for article (PubMed ID: 32552040)
1. Survival nomogram for patients with metastatic siewert type II adenocarcinoma of the esophagogastric junction: a population-based study.
Chen K; Deng X; Yang Z; Yu D; Zhang X; Zhang J; Xie D; He Z; Cheng D
Expert Rev Gastroenterol Hepatol; 2020 Aug; 14(8):757-764. PubMed ID: 32552040
[TBL] [Abstract][Full Text] [Related]
2. Development and validation of a survival nomogram for patients with Siewert type II/III adenocarcinoma of the esophagogastric junction based on real-world data.
Chen J; Xia YJ; Liu TY; Lai YH; Yu JS; Zhang TH; Ooi S; He YL
BMC Cancer; 2021 May; 21(1):532. PubMed ID: 33971833
[TBL] [Abstract][Full Text] [Related]
3. Sites of distant metastases and the cancer-specific survival of metastatic Siewert type II esophagogastric junction adenocarcinoma: a population-based study.
Chen K; Deng X; Yang Z; Yu D; Zhang X; Li W; Xie D; He Z; Cheng D
Expert Rev Gastroenterol Hepatol; 2020 Jun; 14(6):491-497. PubMed ID: 32324423
[TBL] [Abstract][Full Text] [Related]
4. Proposal of a Nomogram for Predicting Survival in Patients with Siewert Type II Adenocarcinoma of the Esophagogastric Junction After Preoperative Radiation.
Liu F; Zhou R; Jiang F; Liu G; Li K; Zhu G
Ann Surg Oncol; 2019 May; 26(5):1292-1300. PubMed ID: 30805805
[TBL] [Abstract][Full Text] [Related]
5. Nomogram predicted survival of patients with adenocarcinoma of esophagogastric junction.
Zhou Z; Zhang H; Xu Z; Li W; Dang C; Song Y
World J Surg Oncol; 2015 Jun; 13():197. PubMed ID: 26055624
[TBL] [Abstract][Full Text] [Related]
6. Risk factors and predictors for tumor site origin in metastatic adenocarcinoma of unknown primary site.
Li X; Shao Y; Sheng L; Zhu J; Wang Z; Guo K; Sun L
Cancer Med; 2021 Feb; 10(3):974-988. PubMed ID: 33405390
[TBL] [Abstract][Full Text] [Related]
7. The risk and prognostic factors for brain metastases in esophageal cancer patients: an analysis of the SEER database.
Cheng S; Yang L; Dai X; Wang J; Han X
BMC Cancer; 2021 Sep; 21(1):1057. PubMed ID: 34563149
[TBL] [Abstract][Full Text] [Related]
8. Prognostic nomogram for Siewert type II adenocarcinoma of the esophagogastric junction patients with and without neoadjuvant radiotherapy: a retrospective cohort study.
Guo Z; Wang N; Liu F; Zhao Q
Am J Transl Res; 2022; 14(1):135-149. PubMed ID: 35173834
[TBL] [Abstract][Full Text] [Related]
9. Predictors of Lymph Node Metastasis in Siewert Type II T1 Adenocarcinoma of the Esophagogastric Junction: A Population-Based Study.
Chen L; Tang K; Wang S; Chen D; Ding K
Cancer Control; 2021; 28():10732748211026668. PubMed ID: 34155922
[TBL] [Abstract][Full Text] [Related]
10. Development and validation of a nomogram to predict the prognosis of patients with gastric cardia cancer.
Shi X; Xu L; Ma B; Wang S
Sci Rep; 2020 Aug; 10(1):14143. PubMed ID: 32839498
[TBL] [Abstract][Full Text] [Related]
11. Development and validation of a nomogram to predict survival outcome among epithelial ovarian cancer patients with site-distant metastases: a population-based study.
Wang B; Wang S; Ren W
BMC Cancer; 2021 May; 21(1):609. PubMed ID: 34034697
[TBL] [Abstract][Full Text] [Related]
12. Development and Validation of Novel Nomograms for Predicting Specific Distant Metastatic Sites and Overall Survival of Patients With Soft Tissue Sarcoma.
Tu Q; Hu C; Zhang H; Kong M; Peng C; Song M; Zhao C; Wang Y; Ma X
Technol Cancer Res Treat; 2021; 20():1533033821997828. PubMed ID: 33706618
[TBL] [Abstract][Full Text] [Related]
13. Development and validation of a nomogram for Siewert II esophagogastric junction adenocarcinoma: a retrospective analysis.
Jin T; Li ZD; Chen ZH; He FJ; Chen ZW; Liang PP; Hu JK; Yang K
Ther Adv Med Oncol; 2024; 16():17588359241229425. PubMed ID: 38322753
[TBL] [Abstract][Full Text] [Related]
14. Risk factors, prognostic factors, and nomograms for bone metastasis in patients with newly diagnosed infiltrating duct carcinoma of the breast: a population-based study.
Huang Z; Hu C; Liu K; Yuan L; Li Y; Zhao C; Hu C
BMC Cancer; 2020 Nov; 20(1):1145. PubMed ID: 33238981
[TBL] [Abstract][Full Text] [Related]
15. Nomogram for predicting the likelihood of liver metastases at initial diagnosis in patients with Siewert type II gastroesophageal junction adenocarcinoma.
Zhang M; Yang W; Yang Y; Cai C; Zhao D; Han B
Sci Rep; 2023 Jul; 13(1):11032. PubMed ID: 37419904
[TBL] [Abstract][Full Text] [Related]
16. Lymph Node Ratio Is an Independent Prognostic Factor for Patients with Siewert Type II Adenocarcinoma of Esophagogastric Junction: Results from a 10-Year Follow-up Study.
Zhang Y; Liu D; Zeng D; Chen C
J Gastrointest Cancer; 2021 Sep; 52(3):983-992. PubMed ID: 32954465
[TBL] [Abstract][Full Text] [Related]
17. A new nomogram and risk classification system for predicting survival in small cell lung cancer patients diagnosed with brain metastasis: a large population-based study.
Shan Q; Shi J; Wang X; Guo J; Han X; Wang Z; Wang H
BMC Cancer; 2021 May; 21(1):640. PubMed ID: 34051733
[TBL] [Abstract][Full Text] [Related]
18. Development and validation of a novel competing risk model for predicting survival of esophagogastric junction adenocarcinoma: a SEER population-based study and external validation.
Wang T; Wu Y; Zhou H; Wu C; Zhang X; Chen Y; Zhao D
BMC Gastroenterol; 2021 Jan; 21(1):38. PubMed ID: 33499821
[TBL] [Abstract][Full Text] [Related]
19. Brain metastases in patients with upper gastrointestinal cancer is associated with proximally located adenocarcinoma and lymph node metastases.
Harada K; Hwang H; Wang X; Abdelhakeem A; Iwatsuki M; Murphy MAB; Maru DM; Weston B; Lee JH; Rogers JE; Trail A; Shanbhag N; Zhao M; Bhutani MS; Nguyen QN; Swisher SG; Ikoma N; Das P; Hofstetter WL; Badgwell BD; Ajani JA
Gastric Cancer; 2020 Sep; 23(5):904-912. PubMed ID: 32347396
[TBL] [Abstract][Full Text] [Related]
20. Establishment of a Prognostic Nomogram for Lung Adenocarcinoma with Brain Metastases.
Huang Z; Tong Y; Tian H; Zhao C
World Neurosurg; 2020 Sep; 141():e700-e709. PubMed ID: 32531436
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
